Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorXiuli Zuo

About this trial

The purpose of this study is to propose a non-invasive screening method by integrating holographic biological theory and artificial intelligence technology. A colorectal cancer risk assessment model will be constructed by analyzing multimodal data including facial features, tongue image characteristics and exhaled gas. The hypothesis of this study is that the model can attain both sensitivity and specificity of 80%.This study will enroll patients aged 18-80 years scheduled to undergo colonoscopy. All participants shall provide informed consent and sign the informed consent form. Patients will be excluded if they have severe cardiac, cerebral, pulmonary or renal dysfunction, or psychiatric disorders precluding colonoscopy, have a history of gastrointestinal surgery, or have taken bismuth agents or other staining medications. Based on estimates from existing literature, the training set will require tongue images, facial images, exhaled gas analysis results and colonoscopic diagnoses from 5000 patients, and the test set will require such data from 6000 patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18-80 years scheduled to undergo colonoscopy.

All patients provide informed consent and sign the informed consent form.

Disqualifiers

Patients with severe cardiac, cerebral, pulmonary or renal dysfunction, or psychiatric disorders that prevent colonoscopy;

Patients with a history of gastrointestinal surgery;

Patients taking bismuth agents or other staining medications.

Trial population

Participants aged 18-80 years who are scheduled to undergo colonoscopy. All participants provide informed consent. This study enrolls subjects preparing for colonoscopic examination to collect multimodal data for constructing an artificial intelligence-based colorectal cancer risk assessment model.

Trial design

Design model

Other

Time perspective

Other

Treatments tested in this trial

  • Multimodal non-invasive detection for colorectal cancer

    Other intervention

    Collection of facial images, tongue images and exhaled gas data from participants. No therapeutic intervention is performed. The collected multimodal data will be used to build an artificial intelligence-based colorectal cancer risk assessment model.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Presence of colonic polyps and colorectal cancer.

Time frame
At the time of enrollment and colonoscopy examination

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Xiuli Zuo

Lead sponsor

Shandong University

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: